$ULBI
ULTRALIFE CORP Stock $ulbi

$ulbi Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923020795 Filed on July 27, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$39.49M	$42.69M
YoY Change	18.82%	32.89%
Cost Of Revenue	$29.71M	$32.10M
YoY Change	12.05%	31.14%
Gross Profit	$9.774M	$10.59M
YoY Change	45.55%	38.48%
Gross Profit Margin	24.75%	24.8%
Selling, General & Admin	$5.770M	$4.942M
YoY Change	6.75%	-4.61%
% of Gross Profit	59.03%	46.68%
Research & Development	$1.869M	$1.754M
YoY Change	-1.42%	4.9%
% of Gross Profit	19.12%	16.57%
Depreciation & Amortization	$760.0K	$987.0K
YoY Change	-6.75%	20.51%
% of Gross Profit	7.78%	9.32%
Operating Expenses	$7.639M	$6.923M
YoY Change	4.63%	1.02%
Operating Profit	$2.135M	$3.665M
YoY Change	-464.33%	362.17%
Interest Expense	-$590.0K	-$440.0K
YoY Change	116.91%	148.59%
% of Operating Profit	-27.63%	-12.01%
Other Income/Expense, Net	-$386.0K	$1.498M
YoY Change	-251.97%	-1402.61%
Pretax Income	$1.749M	$4.723M
YoY Change	-626.81%	596.61%
Income Tax	$446.0K	$1.375M
% Of Pretax Income	25.5%	29.11%
Net Earnings	$1.330M	$3.340M
YoY Change	-656.49%	552.34%
Net Earnings / Revenue	3.37%	7.82%
Basic Earnings Per Share	$0.21	$0.21
Diluted Earnings Per Share	$0.21	$0.21
COMMON SHARES
Basic Shares Outstanding	16.15M	16.14M
Diluted Shares Outstanding	16.30M	16.14M

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.200M	$8.202M
YoY Change	82.14%	60.38%
Cash & Equivalents	$9.223M	$8.202M
Short-Term Investments
Other Short-Term Assets	$6.500M	$4.931M
YoY Change	4.15%	-4.46%
Inventory	$46.63M	$46.06M
Prepaid Expenses
Receivables	$27.19M	$28.63M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$89.55M	$87.83M
YoY Change	13.45%	22.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.17M	$23.31M
YoY Change	-3.34%	4.35%
Goodwill	$37.36M	$37.50M
YoY Change	0.79%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.035M	$11.20M
YoY Change	2.73%	395.53%
Total Long-Term Assets	$86.56M	$87.57M
YoY Change	-2.75%	-3.13%
TOTAL ASSETS
Total Short-Term Assets	$89.55M	$87.83M
Total Long-Term Assets	$86.56M	$87.57M
Total Assets	$176.1M	$175.4M
YoY Change	4.86%	8.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.47M	$18.54M
YoY Change	-14.89%	37.94%
Accrued Expenses	$10.90M	$8.662M
YoY Change	6.3%	28.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.000M	$2.000M
YoY Change	0.0%	0.0%
Total Short-Term Liabilities	$26.39M	$29.20M
YoY Change	-6.04%	31.69%
LONG-TERM LIABILITIES
Long-Term Debt	$24.11M	$22.64M
YoY Change	15.49%	15.72%
Other Long-Term Liabilities	$2.032M	$1.996M
YoY Change	21.46%	50.3%
Total Long-Term Liabilities	$26.14M	$24.64M
YoY Change	15.94%	17.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.39M	$29.20M
Total Long-Term Liabilities	$26.14M	$24.64M
Total Liabilities	$54.35M	$55.86M
YoY Change	3.28%	23.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.63M	-$44.96M
YoY Change	-8.59%	-5.33%
Common Stock	$2.075M	$2.059M
YoY Change	0.88%	0.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$121.6M	$119.5M
YoY Change
Total Liabilities & Shareholders Equity	$176.1M	$175.4M
YoY Change	4.86%	8.12%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$1.330M	$3.340M
YoY Change	-656.49%	552.34%
Depreciation, Depletion And Amortization	$760.0K	$987.0K
YoY Change	-6.75%	20.51%
Cash From Operating Activities	-$890.0K	$1.751M
YoY Change	108.43%	-1083.71%
INVESTING ACTIVITIES
Capital Expenditures	$540.0K	$516.0K
YoY Change	-166.58%	-341.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$540.0K	-$516.0K
YoY Change	-33.42%	141.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.430M	1.562M
YoY Change	86.49%	-464.1%
NET CHANGE
Cash From Operating Activities	-890.0K	1.751M
Cash From Investing Activities	-540.0K	-516.0K
Cash From Financing Activities	2.430M	1.562M
Net Change In Cash	1.000M	2.797M
YoY Change	1438.46%	-440.68%
FREE CASH FLOW
Cash From Operating Activities	-$890.0K	$1.751M
Capital Expenditures	$540.0K	$516.0K
Free Cash Flow	-$1.430M	$1.235M
YoY Change	-472.4%	3330.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	133000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	303000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1876000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000875657
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	ulbi	Dilutive Securities Included In Computation Of Earnings Per Share Amount DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount	0
CY2022Q4	us-gaap	Cash Cash	5713000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27779000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	41192000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4304000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	78988000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21716000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	37428000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	15921000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12069000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2308000	usd
CY2022Q4	us-gaap	Assets Assets	168430000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	18541000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16074000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2320000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2890000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6342000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7949000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	29203000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28913000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22642000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19310000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1917000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1996000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1887000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	55717000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	52027000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4300000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1550000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	833000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	62000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	113000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	25000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3362000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	794000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-165000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-108000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2570000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3299000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8283000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5114000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	117743000	usd
	us-gaap	Profit Loss ProfitLoss	347000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	106000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	362000	usd
	ulbi	Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition	11000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-4000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	32496000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	29200000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-4000	usd
CY2023Q2	ulbi	Dilutive Securities Included In Computation Of Earnings Per Share Amount DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount	4166
CY2023Q2	ulbi	Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock	2500
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2334
CY2022Q2	ulbi	Dilutive Securities Included In Computation Of Earnings Per Share Amount DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount	135163
CY2022Q2	ulbi	Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock	5000
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	20352
	ulbi	Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock	2500
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2157
	ulbi	Dilutive Securities Included In Computation Of Earnings Per Share Amount DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount	135163
	ulbi	Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock	5000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	24751
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8202000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5634000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	81000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	79000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8283000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5713000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	323000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	436000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	651000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4125000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2757000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9442000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9235000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	46063000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	41192000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	93322000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	92660000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	72200000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70944000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21122000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21716000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	760000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	819000	usd
	us-gaap	Depreciation Depreciation	1522000	usd
	us-gaap	Depreciation Depreciation	1635000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	37428000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	73000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	37501000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28223000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12671000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15552000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28060000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12139000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15921000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	227000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	154000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	184000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	293000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	373000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1425693
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.72
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12500
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.07
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	44390
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	99775
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.84
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1294028
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.93
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M28D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	15640000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1188048
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	7.01
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y6M7D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	13124000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	858695
CY2023Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	7.44
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y5M12D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2304000	usd
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	62000	usd
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	62000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	113000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.292	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.305	pure
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	239000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	226000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	480000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	458000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	29000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	23000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	57000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	47000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	268000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	249000	usd
	us-gaap	Lease Cost LeaseCost	537000	usd
	us-gaap	Lease Cost LeaseCost	505000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	494000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	449000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	310000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	520000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	652000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	313000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	245000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	222000	usd
CY2023Q2	ulbi	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	436000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2388000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	221000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	323000	usd
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	172000	usd
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	25000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	62000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	26000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	433000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	132000	usd
CY2023Q2	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	944000	usd
CY2022Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	682000	usd
CY2023Q2	us-gaap	Revenues Revenues	42692000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3665000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1058000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1375000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	3340000	usd
CY2022Q2	us-gaap	Revenues Revenues	32126000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	793000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-115000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	170000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	512000	usd
	us-gaap	Revenues Revenues	74608000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	3691000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	564000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1242000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	19000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2994000	usd
	us-gaap	Revenues Revenues	62499000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	498000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-232000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-81000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000	usd
	us-gaap	Net Income Loss NetIncomeLoss	344000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	42692000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32126000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	74608000	usd

Files In Submission

Name	View Source	Status
0001437749-23-020795-index-headers.html	Edgar Link	pending
0001437749-23-020795-index.html	Edgar Link	pending
0001437749-23-020795.txt	Edgar Link	pending
0001437749-23-020795-xbrl.zip	Edgar Link	pending
ex_545777.htm	Edgar Link	pending
ex_545778.htm	Edgar Link	pending
ex_545779.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ulbi-20230630.xsd	Edgar Link	pending
ulbi20230630_10q.htm	Edgar Link	pending
ulbi-20230630_lab.xml	Edgar Link	unprocessable
ulbi-20230630_pre.xml	Edgar Link	unprocessable
ulbi20230630_10q_htm.xml	Edgar Link	completed
ulbi-20230630_def.xml	Edgar Link	unprocessable
ulbi-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ULBI
ULTRALIFE CORP Stock $ulbi

2023 Q3 Form 10-Q Financial Statement

#000143774923020795 Filed on July 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ULBI ULTRALIFE CORP Stock $ulbi

2023 Q3 Form 10-Q Financial Statement

#000143774923020795 Filed on July 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ULBI
ULTRALIFE CORP Stock $ulbi